IP Library Patent Application 11198024
Patent Application
App. No. 11/198,024

Methods and devices for delivering agents across biological barriers

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/198,024
Abstract

The invention provides for microneedle devices for delivering agents across biological barriers. The microneedles include agent reservoirs integrated into the bodies of the microneedles, themselves.

Claims (49)

1 . A device for delivering an agent across a biological barrier comprising:

a first microneedle;

a first reservoir integrated into the microneedle for holding the agent.

2 . The device of claim 1 , wherein the biological barrier is skin.

3 . The device of claim 1 , wherein the first reservoir comprises an opening through one of the width and depth of the microneedle.

4 . The device of claim 1 , wherein the first reservoir comprises a depression in the microneedle.

5 . The device of claim 1 , wherein the first reservoir takes up a substantial portion of the volume of the first microneedle.

6 . The device of claim 5 , wherein the portion is between about 5% and about 70% of the volume of the first microneedle.

7 . The device of claim 5 , wherein the portion is about 20% -50% of the volume of the first microneedle.

8 . The device of claim 1 , wherein the first microneedle comprises one of stainless steel and titanium.

9 . The device of claim 1 , wherein the first microneedle is between about 150 μm to about 3000 μm long.

10 . The device of claim 1 , wherein the first microneedle is between about 300 μm to about 1500 μm long.

11 . The device of claim 1 , wherein the first microneedle is about 10 μm to about 2000 μm wide.

12 . The device of claim 1 , wherein the first microneedle is about 100 μm to about 500 μm wide.

13 . The device of claim 1 , wherein the agent is suitable for intradermal delivery.

14 . The device of claim 1 , wherein the agent contains a drug.

15 . The device of claim 1 , wherein the agent contains a vaccine.

16 . The device of claim 1 , wherein the reservoir is filled with the agent.

17 . The device of claim 1 , comprising a second microneedle having a second reservoir integrated into the second microneedle.

18 . The device of claim 17 , wherein the first reservoir contains a first agent and the second reservoir contains the same agent.

19 . The device of claim 17 , wherein the first reservoir contains a first agent and the second reservoir contains a different agent.

20 . The device of claim 17 , wherein the first microneedle extends from a first base element, the second microneedle extends from a second base element, and wherein the first and second base elements are coupled to a common substrate.

21 . The device of claim 1 , comprising a depth guard for limiting the depth to which to the first microneedle can pierce the skin of a user.

22 . The device of claim 21 , wherein the depth guard extends from one of the first microneedle, a substrate from which the first microneedle extends, and a base element from which the first microneedle extends.

23 . The device of claim 21 , comprising a base element having a proximal end and a distal end, the base element being wider at its proximal end than at distal end, wherein:

the first microneedle extends from the distal end of the base element, and

the depth guard extends beyond the base element towards the distal end of the first microneedle.

24 . The device of claim 1 , comprising one of a biodegradable stent, wherein the first microneedle is coupled to the biodegradable stent for delivering the agent across a vascular barrier.

25 . The device of claim 1 , comprising a surgical tool, wherein the microneedle is coupled to the surgical tool for delivering the agent across an internal biological barrier.

26 . A method of manufacturing a device for delivering an agent across a biological barrier:

providing a microneedle having an integrated agent reservoir; and

filling the integrated agent reservoir with the agent.

27 . The method of manufacturing a device for transdermal delivery of an agent of claim 26 wherein filling the integrated agent reservoir comprises dipping the microneedle into a solution containing the agent.

28 . The method of manufacturing a device for transdermal delivery of an agent of claim 26 wherein filling the integrated agent reservoir comprises depositing a predetermined volume of a solution containing the agent into the integrated agent reservoir.

29 . The method of manufacturing a device for transdermal delivery of an agent of claim 26 wherein filling the integrated agent reservoir comprises applying a hydrophilic compound to the interior of the integrated agent reservoir and applying a hydrophobic compound to a remainder of the microneedle.

30 . The method of manufacturing a device for transdermal delivery of an agent of claim 26 further comprising

providing a second microneedle having a second integrated agent reservoir;

coupling the first microneedle and the second microneedles to a substrate; and

filling the second integrated agent reservoir with the agent.

31 . A method of delivering an agent transdermally comprising:

providing a microneedle having an integrated agent reservoir filled with the agent;

applying the microneedle against the skin of a patient, thereby piercing the skin and positioning the integrated reservoir beneath the surface of the skin.

32 . A device for transdermal agent delivery comprising:

a substrate;

a plurality of microneedles extending from corresponding base elements coupled to the substrate, wherein the microneedles include openings, which take up between 20-50% of the volume of a corresponding microneedle, and which define integrated agent reservoirs; and

a depth guard extending from at least one of the base elements for limiting the depth to which the plurality of microneedles can be inserted into a surface.

33 . A method of delivering an agent transdermally comprising:

providing a plurality of microneedles coupled to a substrate, wherein at least one of the plurality of microneedles includes an opening defining an integrated reservoir holding the agent;

applying the substrate to the skin of a patient, thereby puncturing the skin to a depth allowed by a depth guard coupled to at least one of the microneedles such that the integrated reservoir is below the surface of the skin.

Assignments (5)
SALE ORDER / RELEASE OF SECURITY INTEREST Recorded Aug 18, 2025
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: ZEALAND PHARMA A/S
Reel/Frame 072509/0386 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded May 28, 2013
From: VALERITAS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 030497/0800 →
CHANGE OF NAME Recorded Aug 8, 2008
From: VALERITAS LLC
To: VALERITAS, INC.
Reel/Frame 021354/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2006
From: BIOVALVE TECHNOLOGIES, INC.
To: VALERITAS LLC
Reel/Frame 018171/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2006
From: MCALLISTER, DEVIN V.; DIMEGLIO, CIRO
To: BIOVALVE TECHNOLOGIES, INC.
Reel/Frame 017163/0863 →